SCHEMBL8273353

SCHEMBL8273353

N#Cc1ccccc1N1CCC(CNC(=O)C(O)C(O)C(=O)N2Cc3ccccc3C2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 9/20 0.61
▸ NAMPT P43490 2/20 0.45
▸ CHRM4 P08173 1/20 0.44
▸ DRD2 P14416 5/20 0.41
▸ DRD4 P21917 5/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39
▸ TAS1R2 Q8TE23 1/20 0.39
▸ DRD3 P35462 4/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ THPO P40225 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8274846 1.00 ADAM17 (0.61) ADAM17NAMPTCHRM4DRD2DRD4
SCHEMBL8213991 0.94 ADAM17 (0.55) ADAM17NAMPTCHRM4DRD2DRD4
SCHEMBL8213656 0.90 ADAM17 (0.54) ADAM17NAMPTCHRM4MEN1KMT2A
SCHEMBL8276637 0.90 ADAM17 (0.53) ADAM17NAMPTDRD2DRD4TAS1R3
SCHEMBL8221362 0.90 ADAM17 (0.66) ADAM17CHRM4DRD2DRD4DRD3
SCHEMBL8222661 0.89 ADAM17 (0.53) ADAM17CHRM4MEN1KMT2A
SCHEMBL8221255 0.87 ADAM17 (0.55) ADAM17NAMPTCHRM4MEN1KMT2A
SCHEMBL8222707 0.87 ADAM17 (0.49) ADAM17NAMPTMEN1KMT2AADAM10
SCHEMBL8221026 0.87 ADAM17 (0.51) ADAM17NAMPTCHRM4DRD2MEN1
SCHEMBL8221408 0.87 ADAM17 (0.51) ADAM17NAMPTCHRM4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback